A Novel Peptide Strategy to Prevent Surface-Triggered Thrombosis – JTH
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn about a recent article by Adam Hansen et al, adding:
”Peptide-mediated inhibition of surface-initiated thrombogenesis
A designed peptide, P12, blocked thrombus formation triggered by artificial surfaces while leaving normal clotting intact.
In testing, it curbed surface-initiated thrombogenesis without impairing physiological hemostasis.
The authors see translational promise for treating device-related thrombosis and for engineering antithrombotic surfaces and coatings that resist clotting without raising bleeding risk.”
Title: Peptide-mediated inhibition of surface-initiated thrombogenesis
Authors: Adam Hansen, Bernard Essuman, Georgios Kementzidis, Nabila Jaman Tripti, Fubao Lin, Volodymyr Chernyshenko, Richard A.F. Clark, Yuefan Deng, Miriam Rafailovich, Dennis Galanakis

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 17, 2026, 05:47Multidisciplinary Teams Kick Off SAHF MASAC ES 2026 with Pre-Symposium Workshops – South African Haemophilia Foundation
-
Nov 17, 2026, 05:41Boitumelo Malatji: South African Delegation Advances Advocacy Strategies at NNHF Southern Africa Workshop
-
Nov 17, 2026, 05:36Joining the PACTA Uganda Mental Health and Addiction Community Camp 2026 – Tackle Sickle Cell Africa
-
Nov 17, 2026, 05:30Nathan Connell: Women’s Hematology Summit 2027 to Address Hematologic Health Across the Lifespan
-
Nov 17, 2026, 05:25Mane Kurghinyan: Representing Armenia and HemAI Dynamics at the Falling Walls Lab Global Finale 2026
-
Nov 17, 2026, 01:27X. Long Zheng: Optimizing Treatment in Immune TTP
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH